Venous thromboembolism in cancer patients: risk assessment, prevention and management
| Autor: | Deepali N. Tukaye, Heidi L. Brink, Ragavendra R. Baliga |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
medicine.medical_specialty
business.industry Deep vein Cancer Venous Thromboembolism 030204 cardiovascular system & hematology medicine.disease Risk Assessment Thrombosis Pulmonary embolism 03 medical and health sciences Venous thrombosis 0302 clinical medicine medicine.anatomical_structure Embolism Neoplasms 030220 oncology & carcinogenesis medicine Humans Molecular Medicine Cardiology and Cardiovascular Medicine Risk assessment Intensive care medicine business Venous thromboembolism |
| Zdroj: | Future Cardiology. 12:221-235 |
| ISSN: | 1744-8298 1479-6678 |
| DOI: | 10.2217/fca.15.87 |
| Popis: | Thrombosis and thromboembolic events contribute to significant morbidity in cancer patients. Venous thrombosis embolism (which includes deep vein thrombosis and pulmonary embolism) accounts for a large percentage of thromboembolic events. Appropriate identification of cancer patients at high risk for venous thromboembolism and management of thromboembolic event is crucial in improving the quality of care for cancer patients. However, thromboembolism in cancer patients is a complex problem and the management has to be tailored to each individual. The focus of this review is to understand the complex pathology, physiology and risk factors that drive the process of venous thrombosis and embolism in cancer patients and the current guidelines in management. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|